In PCa, hTERT expression positively correlates with clinicopathological features such as Gleason score, tumor differentiation, and serum levels of prostate-specific antigen (PSA), as the most commonly used biomarker in diagnosis of PCa, along with recurrence and worse survival in the affected patients [122, 123]. This evidence concerns the gene KLK3 and neoplasm.